CorMedix Inc.
For the period ended May 14, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 14, 2026 · Filed May 14, 2026
CRMD$5.32+1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (In Thousands, Except Per Share Data)
(In Thousands, Except Per Share Data)
| For the Three Months EndedMarch 31, | ||||
|---|---|---|---|---|
| 2026 · 2025 | ||||
| Revenue: | ||||
| Product sales, net | $121,916 | $39,082 | ||
| Contract revenue | 5,511 | - | ||
| Total Revenue | $127,427 | $39,082 | ||
| Cost of sales (exclusive of amortization of intangibles) | $12,005 | 1,545 | ||
| Amortization of intangibles | 10,300 | 52 | ||
| Gross profit | $105,122 | $37,485 | ||
| Operating Expenses: | ||||
| Research and development | $7,212 | $3,193 | ||
| Selling and marketing | 12,532 | 4,474 | ||
| General and administrative | 21,720 | 9,693 | ||
| Total Operating Expenses | $41,464 | $17,360 | ||
| Income From Operations | $63,658 | $20,125 | ||
| Other (Expense) Income: | ||||
| Unrealized loss on marketable security | $(3,546) | $ | - | |
| Change in contingent consideration | (4,199) | - | ||
| Other non-operating (expense) income, net | (268) | 519 | ||
| Total Other (Expense) Income | $(8,013) | $519 | ||
| Income before income taxes | $55,645 | $20,644 | ||
| Tax expense | 17,044 | — | ||
| Net Income | $38,601 | $20,644 | ||
| Net Income Per Common Share – Basic | $0.48 | $0.32 | ||
| Net Income Per Common Share - Diluted | $0.43 | $0.30 | ||
| Weighted Average Common Shares Outstanding – Basic | 79,509 | 65,244 | ||
| Weighted Average Common Shares Outstanding – Diluted | 92,985 | 68,975 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.